Quantum Labs
Bahasa Indonesia
CJC-1295 + Ipamorelin 5 mg + 5 mgPaket 10 vial6 stokHemat 22%
Unggulanpeptideintermediate6 stok

CJC-1295 + Ipamorelin 5 mg + 5 mg

Stack klasik GHRH + mimetik ghrelin

CJC-1295 and Ipamorelin research stack, Australian-shipped. Lab-verified to ≥99% purity.

Dosis
5mg + 5mg / vial
Bentuk
Serbuk liofilisasi
Paket
Paket 10 vial

Hanya untuk keperluan penelitian. Senyawa ini dijual secara ketat untuk penelitian in-vitro dan keperluan laboratorium, dan tidak dimaksudkan untuk konsumsi manusia atau penggunaan terapeutik. Dengan membeli, Anda menegaskan bahwa Anda adalah peneliti yang memenuhi syarat dan menyetujui penyangkalan lengkap kami.

Rp 3.090.906 IDR
Hemat 22%
Paket 10 vial
Sebelumnya Rp 3.962.700 IDR
Dijual sebagai paket 10 vial

Tersisa 6 paket

🧪Terverifikasi laboratorium
✓Diuji pihak ketiga
⚡Pengiriman cepat ke seluruh dunia
🔒Pembayaran kartu yang aman
Ikhtisar

Vial riset gabungan yang memasangkan analog GHRH CJC-1295 dengan mimetik ghrelin selektif Ipamorelin. Stack sekretagog GH dual-mekanisme yang paling banyak dikaji dalam riset peptida.

CJC-1295 and Ipamorelin are a long-standing pair in growth-hormone secretagogue research. CJC-1295 is a 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective ghrelin receptor agonist (a 'GHS' or growth-hormone secretagogue). The two compounds act on different receptors but converge on the somatotrophs of the anterior pituitary, where they amplify pulsatile growth-hormone release in pre-clinical models.

Quantum Labs supplies the pair as a pre-portioned research stack — two lyophilised vials shipped together, each HPLC-verified to ≥99% purity. Australian-shipped from local stock; supplied for laboratory research use only.

Mekanisme

CJC-1295 mendukung sinyal reseptor GHRH basal, sementara Ipamorelin mendorong pulsa reseptor ghrelin selektif. Riset menunjukkan pola pelepasan GH yang sinergis dan mendekati fisiologis pada subjek studi.

Laporan laboratorium

Diverifikasi HPLC terhadap spesifikasi kemurnian ≥99%. Diuji secara independen oleh laboratorium pihak ketiga terakreditasi.

CJC-1295: DAC vs no-DAC

CJC-1295 exists in two research forms: with Drug Affinity Complex (DAC) and without. The DAC variant binds albumin in plasma, extending the half-life from minutes to days. Research designs targeting acute pulsatile GH release typically use the no-DAC form (modified GRF 1-29); studies modelling sustained GH elevation use the DAC variant. Our supply is the no-DAC research-grade form unless otherwise specified.

FAQ peneliti

CJC-1295 + Ipamorelin — pertanyaan yang sering diajukan

What is the CJC-1295 + Ipamorelin stack?

It is a research pairing of two growth-hormone secretagogues: CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). The two compounds act on different receptors but converge on stimulating pulsatile growth-hormone release in pre-clinical models.

How does CJC-1295 differ from Ipamorelin?

CJC-1295 mimics growth-hormone-releasing hormone (GHRH), binding the GHRH receptor on pituitary somatotrophs. Ipamorelin mimics ghrelin, binding the growth-hormone secretagogue receptor (GHSR-1a). The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone.

Is CJC-1295 + Ipamorelin legal in Australia?

Both compounds are restricted for human therapeutic supply in Australia and remain available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies the stack for research use only.

What does selective mean for Ipamorelin?

Ipamorelin is described as a selective ghrelin agonist because it activates the GH-release pathway with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from earlier-generation GHS molecules. This selectivity has made it a preferred research tool for isolating GH-specific effects.

What is the typical CJC-1295 + Ipamorelin research dosage?

Published research protocols have used wide dose ranges depending on the model and species. Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.

Are CJC-1295 and Ipamorelin used together?

Yes — combined-administration research is common precisely because the two compounds act on independent receptors and produce a synergistic GH-release response. The combination is a standard tool in growth-hormone secretagogue research.

Bacaan lanjutan

Panduan terkait CJC-1295 + Ipamorelin

Senyawa terkait

Peneliti juga menelusuri

TesamorelinPaket 10 vialHemat 18%

Tesamorelin

Serbuk liofilisasi

10 mg · 3 strengths

Analog GHRH yang distabilkan

Dalam 1 stack
Rp 5.872.752 IDR
Hemat 18%
Paket 10 vial
Sebelumnya Rp 7.161.930 IDR
Lihat detail →
Melanotan IIUnggulanPaket 10 vialHemat 22%

Melanotan II

Serbuk liofilisasi

10 mg

Peptida riset analog α-MSH

Rp 1.854.564 IDR
Hemat 22%
Paket 10 vial
Sebelumnya Rp 2.377.620 IDR
Lihat detail →